Convicted “Pharma Bro” Martin Shkreli has been ordered to return $64 million in profits his company made by inflating the price of a life-saving drug, a federal judge in New York ruled on Friday.
Shkreli, who is currently serving a seven-year prison sentence for securities fraud after he was convicted in 2017, is also barred from ever working in the pharmaceutical industry again.
US District Judge Denise Cote handed down the ruling on Friday, ending a weeks-long civil lawsuit brought against Shkreli by the Federal Trade Commission and seven states.
Shkreli, who is currently behind bars at a low-security federal prison in Allenwood, Pennsylvania, became one of the most-hated executives in America.
In 2015,Shkreli’s company, Turing Pharmaceuticals, acquired the rights to Daraprim, a